Courtesy pink.pharmaintelligence.informa.com
A drug which doctors often prescribe to treat blood cancer might come in handy in the treatment of COVID-19.
According to scientists, cancer drug acalabrutinib – which is associated with reduced respiratory distress – can bring down the overactive immune response in COVID-19 patients.
Researchers at National Cancer Institute in the US say that acalabrutinib blocked the protein Bruton yrosine kinase (BTK) in COVID-19 patients and clinically benefitted some of them.
Hence it is a potential therapeutic for the novel coronavirus disease, which has killed 399,000 people across the world so far.
The study included 19 patients diagnosed with coronavirus who required hospitalisation. Eight had been on ventilators for a day or two, of whom four came out of it and were eventually discharged.
Two of the patients in this group died.
Published in the journal Science Immunology, the study observed that the findings should not be considered clinical advice, as it remains to be tested in a randomised, controlled clinical trial.
Bhubaneswar: A youth was critically injured reportedly in an armed attack by some miscreants in…
Lucknow: Imagine a man trying to kill his wife because she confided in him that she…
Kendrapada: Lightning strike during northwesterly killed two more persons including a woman in Odisha's Kendrapada district…
New Delhi: More than five weeks after being arrested by Enforcement Directorate, Arvind Kejriwal has not…
Bhubaneswar: With BJD president and Chief Minister Naveen Patnaik taking the lead in kicking off…
Bengaluru: A consumer court here has ordered Swiggy to pay Rs 3,000 as compensation and…
Bhubaneswar: What is common between Nandan Nilekani, Kota Harinarayana, Narayana Murthy, Damodar Acharya, BK Syngal,…
Bhubaneswar: The Odisha Pradesh Congress Committee (OPCC) has proposed to AICC for nominating Sofia Firdous…